This series began with a photograph of a newborn and a feeding tube. We’ll end it with an invitation.

Everything we’ve shared points to one goal: safe nasogastric tube placement can be achievable, but the tools we give clinicians have to drive that safety — at the bedside, in real time, on a real ward, in every health system.

That’s the standard Enteral Access Technologies is working toward. DoubleCHEK — UKCA marked, CE marked, and FDA 510(k) cleared, with a place on the NHS Enteral Framework and availability across Europe and the United States — is our contribution. Two key checks, one safe placement, designed to support clinicians and protect patients while reducing unnecessary X-rays, delays in feeds and medications, lung injury and the overall cost of nasogastric tube insertion.

We’re an ambitious medical device company with a global mission, born from a very personal story. If you’re a clinician, a nutrition lead, or a procurement team in the UK, Europe or the US who cares about this, we’d love to talk — a conversation, a demo, or a trial at your facility.

Because every patient with a feeding tube is someone’s lucky one. Let’s make sure more of them are — everywhere.

Get in touch: enteralaccesstech.com